Rare and recalcitrant cancers for establishing the predictive power of patient-derived xenografts (pdxs)
Ended Awarded Last action
- Contract number
- 75N91018F00075
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,812,417
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 73% obligated
-
- $19,812,417.00 Current, with exercised options
- $26,992,416.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $19,812,417 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Leidos Biomedical Research Inc. The $26,992,416.00 contract is for the acquisition of matched tumor and blood specimens to support the development of clinically annotated patient-derived cancer models for the NCI Patient-Derived Models Repository. This repository aims to provide researchers with models to gain insights into tumor biology and predict response to cancer treatments. The contract has subcontracts with Ozark Health Ventures LLC and Corewell Health, non-profit hospitals that will supply the required specimens. Leidos Biomedical Research, a subsidiary of Leidos Holdings, Inc., has a history of providing research, development, and production services to federal agencies like the NIH, supporting biomedical research programs. This contract is not set aside for any specific business type.
Quick answers
Who was awarded contract 75N91018F00075?
75N91018F00075 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 28, 2018.
How much is contract 75N91018F00075 worth?
The government has obligated $19,812,417 on 75N91018F00075. Its potential value, with all options, is $26,992,416.
Is contract 75N91018F00075 an order under another contract?
Yes. 75N91018F00075 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00075 competed?
The extent of competition for 75N91018F00075 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award